CJC-1295 With DAC

Chemical & physical information

Peptide class: Synthetic GHRH analogue with Drug Affinity Complex (DAC)
Molecular formula: C₁₆₅H₂₆₉N₄₇O₄₆
Molecular weight: ~3647.28 g/mol
Structure: Modified 30-amino acid peptide with albumin-binding affinity
Form: Lyophilised solid
Typical purity: ≥98–99% (analytical method dependent)

Research context

CJC-1295 (with DAC) is a modified analogue of growth hormone releasing hormone (GHRH), incorporating a Drug Affinity Complex (DAC) to enable extended stability and prolonged interaction within experimental systems.

It is commonly investigated in laboratory models focused on endocrine signalling dynamics and peptide–protein interactions, particularly those examining extended-duration activity profiles.

This compound is utilised in experimental settings exploring:

• Peptide-mediated receptor signalling over extended timeframes
• Endocrine system regulation and signalling persistence
• Peptide–albumin binding interactions and stability mechanisms
• Structure–function relationships of modified GHRH analogues

The DAC modification allows the peptide to associate with circulating proteins in research models, providing a framework for studying sustained signalling behaviour compared to shorter-acting analogues.

Quality & handling

• Supplied as a lyophilised solid for laboratory preparation
• Analytical purity verified using standard chromatographic techniques
• Suitable for controlled in vitro and pre-clinical research workflows
• Batch-specific documentation available

For research use only